Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2009
10/14/2009CN100548331C Compound cape-jasmine salted-fermented beans total extract and its preparation and use
10/14/2009CN100548320C Bone metabolism improving agent
10/14/2009CN100548318C Water fennel total phenolic acid preparing process, and medicinal preparation using same as active component and use
10/14/2009CN100548315C Silkworm health-care product and its preparing process
10/14/2009CN100548311C Application of sodium thiosulfate in the preparation of clinical selenium-complementing and cancer-treating medicine and fast- preparing method for the same
10/14/2009CN100548302C Female hormone-containing patch
10/14/2009CN100548293C Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
10/14/2009CN100548291C MCH antagonists for the treatment of obesity
10/14/2009CN100548193C Peony massage pillow and its manufacture method
10/14/2009CN100548159C Superfine peanut powder rich in biological active component and its processing method
10/14/2009CN100548155C Improved dietary fiber containing materials comprising low molecular weight glucan
10/14/2009CN100548145C Art for producing milk production increasing agent by utilizing earth-worm extractive as raw material
10/14/2009CN100548135C Method for producing tea of loquat flower petals
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601845 Optically detectable organophosphonates
10/13/2009US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601723 For treating asthma and improving insulin sensitivity
10/13/2009US7601718 1,5-Dihydro-pyrazolo[4,3-c]pyridazin-6-one derivatives; glycogen synthase kinase-3 (CSK) inhibitors; nervous system, psychological, and neurodegenerative disorders; diabetes, psychiatry, multiple sclerosis (MS), myocardial infarction, reperfusion/ischemia, alopecia, and stroke
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601705 Polymer controlled induced viscosity fiber system and uses thereof
10/13/2009US7601523 Method for production of arachidonic acid
10/13/2009US7601157 Devices and methods for the restoration of a spinal disc
10/13/2009CA2504747C Pharmaceutical antidiabetic composition
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/13/2009CA2419416C Tetrazolyl-phenyl acetamide glucokinase activators
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2334775C Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
10/13/2009CA2319515C Anhydrous topical skin preparations
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/08/2009WO2009124259A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009WO2009123986A1 Apoptosis signal-regulating kinase 1 inhibitors
10/08/2009WO2009123881A1 Purine derivatives as a3 receptor- selective agonists
10/08/2009WO2009123364A1 Mineral absorption accelerator and iron deficiency anemia improver or food composition
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123257A1 Soft capsule coating and soft capsule
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123194A1 Heterocyclic compound
10/08/2009WO2009123183A1 Antiviral agent and antiviral composition
10/08/2009WO2009123164A1 Heterocyclic derivative having inhibitory activity on endothelial lipase
10/08/2009WO2009122983A1 Ketone accumulation inhibitor
10/08/2009WO2009122707A1 1,3-dihydroisobenzofuran derivative
10/08/2009WO2009121959A1 Use of glycosaminoglycan for restoring glycocalyx
10/08/2009WO2009121945A2 New formulations, tablets comprising such formulations, their use and process for their preparation
10/08/2009WO2009121940A1 Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester
10/08/2009WO2009121939A2 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009WO2009121741A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009121740A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009102467A3 Devices, formulations, and methods for delivery of multiple beneficial agents
10/08/2009WO2009093210A3 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
10/08/2009WO2009093209A3 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR d] PYRAZOLO [1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
10/08/2009WO2009088738A3 Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
10/08/2009WO2009042435A8 Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009WO2008107910A3 Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same
10/08/2009WO2008072799A9 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090253781 Therapeutic compositions
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253764 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
10/08/2009US20090253744 Acylated piperidine derivatives as melanocortin-4 receptor modulators
10/08/2009US20090253738 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253704 PYRROLOTRIAZINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253689 Organic Compounds
10/08/2009US20090253680 Selected cgrp-antagonists, processes for preparing them and their use as pharmaceutical compositions
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253676 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
10/08/2009US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists
10/08/2009US20090253642 Mimicking the metabolic effects of caloric restriction by administration of glucose anti-metabolites
10/08/2009US20090253641 Methods for preventing or treating insulin resistance
10/08/2009US20090253625 GLP-1, exendin-4, peptide analogs and uses thereof
10/08/2009US20090253623 Gh secretagogues and uses thereof
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253614 Oral insulin therapies & protocol
10/08/2009US20090252817 Methods for the treatment or prevention of Diabetes Mellitus and other metabolic imbalances
10/08/2009US20090252790 Tablet formulation
10/08/2009US20090252758 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
10/08/2009US20090252753 Immunomodulation for autoimmune type-2 diabetes
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009US20090252727 Glucagon receptor antagonists
10/08/2009US20090252694 Novel Chalcone Derivatives, Pharmaceutically Acceptable Salt, Method for Preparation and Uses Thereof
10/08/2009US20090252672 Nasal delivery of therapeutic agents using tight junction agonists
10/08/2009CA2728889A1 Solid state forms of a pharmaceutical
10/08/2009CA2720450A1 New formulations, tablets comprising such formulations, their use and process for their preparation
10/08/2009CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009CA2720037A1 Purine derivatives as a3 adenosine receptor-selective agonists
10/08/2009CA2720011A1 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009CA2719507A1 Oxymethylene aryl compounds and uses thereof
10/08/2009CA2719362A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009CA2719358A1 Antiviral agent and antiviral composition
10/08/2009CA2718645A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/08/2009CA2717537A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/07/2009EP2107110A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
10/07/2009EP2107072A1 Sodium absorption inhibitor, potassium absorption inhibitor, phosphorus absorption inhibitor and preventive agent, therapeutic agent and food containing the same
10/07/2009EP2106398A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd)
10/07/2009EP2106260A1 Insulin sensitisers and methods of treatment
1 ... 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 ... 1298